189 related articles for article (PubMed ID: 10439233)
1. Efficacy of finasteride 1 mg in the treatment of androgenetic alopecia in men.
Olsen EA
Exp Dermatol; 1999 Aug; 8(4):302-3. PubMed ID: 10439233
[No Abstract] [Full Text] [Related]
2. Improvement in androgenetic alopecia (stage V) using topical minoxidil in a retinoid vehicle and oral finasteride.
Walsh DS; Dunn CL; James WD
Arch Dermatol; 1995 Dec; 131(12):1373-5. PubMed ID: 7492124
[No Abstract] [Full Text] [Related]
3. Finasteride in the treatment of Japanese men with male pattern hair loss.
Kawashima M; Hayashi N; Igarashi A; Kitahara H; Maeguchi M; Mizuno A; Murata Y; Nogita T; Toda K; Tsuboi R; Ueki R; Yamada M; Yamazaki M; Matsuda T; Natsumeda Y; Takahashi K; Harada S
Eur J Dermatol; 2004; 14(4):247-54. PubMed ID: 15319158
[TBL] [Abstract][Full Text] [Related]
4. [Therapy of androgenetic alopecia with finasteride. What must be considered in consultation and drug prescribing].
Wolff H; Kunte C
MMW Fortschr Med; 1999 Sep; 141(37):38-40. PubMed ID: 10897972
[TBL] [Abstract][Full Text] [Related]
5. Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss.
Roberts JL; Fiedler V; Imperato-McGinley J; Whiting D; Olsen E; Shupack J; Stough D; DeVillez R; Rietschel R; Savin R; Bergfeld W; Swinehart J; Funicella T; Hordinsky M; Lowe N; Katz I; Lucky A; Drake L; Price VH; Weiss D; Whitmore E; Millikan L; Muller S; Gencheff C
J Am Acad Dermatol; 1999 Oct; 41(4):555-63. PubMed ID: 10495375
[TBL] [Abstract][Full Text] [Related]
6. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia.
Drake L; Hordinsky M; Fiedler V; Swinehart J; Unger WP; Cotterill PC; Thiboutot DM; Lowe N; Jacobson C; Whiting D; Stieglitz S; Kraus SJ; Griffin EI; Weiss D; Carrington P; Gencheff C; Cole GW; Pariser DM; Epstein ES; Tanaka W; Dallob A; Vandormael K; Geissler L; Waldstreicher J
J Am Acad Dermatol; 1999 Oct; 41(4):550-4. PubMed ID: 10495374
[TBL] [Abstract][Full Text] [Related]
7. Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year results.
Price VH; Menefee E; Sanchez M; Kaufman KD
J Am Acad Dermatol; 2006 Jul; 55(1):71-4. PubMed ID: 16781295
[TBL] [Abstract][Full Text] [Related]
8. 5 alpha-reductase and finasteride in pattern alopecia and acne.
Burkhart CG; Burkhart CN
J Drugs Dermatol; 2004; 3(4):363-4. PubMed ID: 15303779
[No Abstract] [Full Text] [Related]
9. Advances in the treatment of male androgenetic alopecia: a brief review of finasteride studies.
Whiting DA
Eur J Dermatol; 2001; 11(4):332-4. PubMed ID: 11399540
[TBL] [Abstract][Full Text] [Related]
10. Minoxidil vs finasteride in the treatment of men with androgenetic alopecia.
Saraswat A; Kumar B
Arch Dermatol; 2003 Sep; 139(9):1219-21. PubMed ID: 12975174
[No Abstract] [Full Text] [Related]
11. Finasteride--an update and review.
Cather JC; Lane D; Heaphy MR; Nelson BR
Cutis; 1999 Sep; 64(3):167-72. PubMed ID: 10500917
[No Abstract] [Full Text] [Related]
12. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia.
Finasteride Male Pattern Hair Loss Study Group
Eur J Dermatol; 2002; 12(1):38-49. PubMed ID: 11809594
[TBL] [Abstract][Full Text] [Related]
13. Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old.
Camacho FM; García-Hernández MJ; Fernández-Crehuet JL
Br J Dermatol; 2008 May; 158(5):1121-4. PubMed ID: 18363752
[TBL] [Abstract][Full Text] [Related]
14. Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss).
Shapiro J; Kaufman KD
J Investig Dermatol Symp Proc; 2003 Jun; 8(1):20-3. PubMed ID: 12894990
[TBL] [Abstract][Full Text] [Related]
15. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
Price VH; Roberts JL; Hordinsky M; Olsen EA; Savin R; Bergfeld W; Fiedler V; Lucky A; Whiting DA; Pappas F; Culbertson J; Kotey P; Meehan A; Waldstreicher J
J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):768-76. PubMed ID: 11050579
[TBL] [Abstract][Full Text] [Related]
16. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
Gubelin Harcha W; Barboza Martínez J; Tsai TF; Katsuoka K; Kawashima M; Tsuboi R; Barnes A; Ferron-Brady G; Chetty D
J Am Acad Dermatol; 2014 Mar; 70(3):489-498.e3. PubMed ID: 24411083
[TBL] [Abstract][Full Text] [Related]
17. [Finasteride: a new drug for the treatment of male hirsutism and androgenetic alopecia?].
Spinucci G; Pasquali R
Clin Ter; 1996 Jun; 147(6):305-15. PubMed ID: 8925640
[TBL] [Abstract][Full Text] [Related]
18. Finasteride treatment may not prevent telogen effluvium after minoxidil withdrawal.
Tosti A; Iorizzo M; Vincenzi C
Arch Dermatol; 2003 Sep; 139(9):1221-2. PubMed ID: 12975176
[No Abstract] [Full Text] [Related]
19. Female androgenetic alopecia treated by finasteride: a case forward.
Valsecchi R; Leghissa P; Riva M
Acta Derm Venereol; 2004; 84(6):488-9. PubMed ID: 15844649
[No Abstract] [Full Text] [Related]
20. Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss).
Kaufman KD; Rotonda J; Shah AK; Meehan AG
Eur J Dermatol; 2008; 18(4):400-6. PubMed ID: 18573712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
